Bacterial News and Research

RSS

Advances in nasal delivery of antibiotics

In a recent study published in the Journal of Drug Delivery Science and Technology, researchers reviewed the advances and challenges in the intranasal delivery of antibiotics.

17 Oct 2022

Inhalation therapeutics against COVID-19

A recent study published in the Pulmonary Pharmacology & Therapeutics journal described different inhalation therapeutic agents for treating respiratory viral infections like coronavirus disease 2019 (COVID-19).

17 Oct 2022

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Bacterial infectious diseases are still a huge contributor to global disease burden and with antibiotic resistance on the rise worldwide there is an urgent need for novel treatment strategies against bacteria.

14 Oct 2022

Comprehensive analysis reveals the burden of antimicrobial resistance in the WHO European Region

The latest and most comprehensive analysis of antimicrobial resistance (AMR) and its impact in the entire WHO European Region (53 countries) was published in a peer-reviewed paper today in The Lancet Global Health.

14 Oct 2022

Pain-sensing neurons protect the gut from inflammation and associated tissue damage

Neurons that sense pain protect the gut from inflammation and associated tissue damage by regulating the microbial community living in the intestines, according to a study from researchers at Weill Cornell Medicine.

14 Oct 2022

Chinese scientists reveal a previously undefined pathway by which Mtb counteracts host immunity

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a leading infectious threat to public health worldwide.

13 Oct 2022

DTU researchers create a new tool in the fight against resistant bacteria

According to the WHO, antibiotic resistance is one of the biggest threats to public health. DTU researchers have created a new tool in the fight against resistant bacteria that, based on 214,000 microbiome samples, can create an overview of the problem across countries, people and environments.

13 Oct 2022

New technology for producing oxygen within cells

Oxygen is vital for life, and clinicians can provide supplemental oxygen to patients through face masks and nasal tubes, but there are no methods available for delivering oxygen directly into cells.

13 Oct 2022

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments - a threat that has been met with insufficient funding and dwindling inspiration, as commercial incentives for developing new antibiotics have fallen.

13 Oct 2022

Novel testing method could simplify widespread tuberculosis screening

Tuberculosis can be tough to detect. Diagnosis usually requires coughing up a sputum sample from the lungs, which can be unpleasant, impractical, and even hazardous.

13 Oct 2022

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Organ damage occurs in up to 70 percent of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.

13 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

11 Oct 2022

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia

A recent Respiratory Medicine Case Reports study reported the pulmonary tomographic findings in severely infected COVID-19 patients with critical pneumonia.

11 Oct 2022

Independent Task Force report outlines a One Health approach to address risk factors for future pandemics

The Independent Task Force on COVID-19 and other Pandemics (www.independentcovidtaskforce.org) announced that their report "Pandemic Origins and a One Health Approach to Preparedness and Prevention: Solutions Based on SARS-CoV-2 and Other RNA Viruses" has been published in the Proceedings of the National Academy of Sciences.

10 Oct 2022

Bacterial News and Research

Advances in nasal delivery of antibiotics

Inhalation therapeutics against COVID-19

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Comprehensive analysis reveals the burden of antimicrobial resistance in the WHO European Region

Pain-sensing neurons protect the gut from inflammation and associated tissue damage

Chinese scientists reveal a previously undefined pathway by which Mtb counteracts host immunity

DTU researchers create a new tool in the fight against resistant bacteria

New technology for producing oxygen within cells

Potent antibiotic-loaded bone-cement could be used to treat bone infections

Novel testing method could simplify widespread tuberculosis screening

Changes in the skin microbiome may contribute to development of GVHD after stem cell transplant

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Pulmonary radiological patterns in patients diagnosed with SARS-CoV-2 pneumonia

Independent Task Force report outlines a One Health approach to address risk factors for future pandemics

What is the impact of monkeypox infection on the hemostatic system?

What is the association between maternal weight status and the composition of the milk microbiome?

Myocarditis may be attributable to monkeypox infection

Early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis begins

Immune cell defect tied to the risk of developing rare bacterial infection

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News